Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:prostate tumorous lesion size measurement
go back to main search page
Accession:CMO:0000885 term browser browse the term
Definition:Any measurement of the size of an individual tumorous lesion in the prostate, or of the amount of the prostate occupied by tumorous lesions. A tumorous lesion is one which is or has the potential to become a tumor, that is, a neoplasm or new growth of tissue in which cell multiplication is more or less uncontrolled and progressive. Tumorous lesions include tumors, preneoplastic lesions, and hyperplastic lesions composed of histologically normal cells.



show annotations for term's descendants           Sort by:
area of ventral prostate occupied by tumorous lesions to total ventral prostate area ratio term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Prcr1 Prostate cancer resistance QTL 1 IDA RGD PMID:15805257 RGD:1358944 NCBI chr 2:72,532,993...157,142,209 JBrowse link
Q Prcr2 Prostate cancer resistance QTL 2 IDA RGD PMID:15805257 RGD:1358944 NCBI chr 1:20,763,158...44,095,856 JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    organ measurement 485
      organ lesion measurement 140
        prostate lesion measurement 4
          prostate tumorous lesion measurement 4
            prostate tumorous lesion size measurement 2
              prostate tumorous lesion area measurement + 2
paths to the root